Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins

Detecting the targets of drugs and other molecules in intact cellular contexts is a major objective in drug discovery and in biology more broadly. Thermal proteome profiling (TPP) pursues this aim at proteome-wide scale by inferring target engagement from its effects on temperature-dependent protein denaturation. However, a key challenge of TPP is the statistical analysis of the measured melting curves with controlled false discovery rates at optimal proteome coverage and detection power. We present non-parametric analysis of response curves (NPARC), a statistical method for TPP based on functional data analysis and nonlinear regression. We evaluate NPARC on five independent TPP datasets and observe that it is able to detect subtle changes in any region of the melting curves, reliably detects the known targets, and outperforms a melting point-centric, single-parameter fitting approach in terms of specificity and sensitivity. NPARC can be combined with established analysis of variance (ANOVA) statistics and enables flexible, factorial experimental designs and replication levels. To facilitate access to a wide range of users, a freely available software implementation of NPARC is provided.

[1]  W. Huber,et al.  Nonparametric Analysis of Thermal Proteome Profiles Reveals Novel Drug-binding Proteins , 2019, Molecular & Cellular Proteomics.

[2]  N. Jehmlich,et al.  Thermal proteome profiling allows quantitative assessment of interactions between tetrachloroethene reductive dehalogenase and trichloroethene. , 2019, Journal of proteomics.

[3]  P. Nordlund,et al.  Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay. , 2019 .

[4]  P. Nordlund,et al.  Identifying purine nucleoside phosphorylase as the target of quinine using cellular thermal shift assay , 2019, Science Translational Medicine.

[5]  M. Savitski,et al.  Thermal proteome profiling in bacteria: probing protein state in vivo , 2018, Molecular systems biology.

[6]  Pär Nordlund,et al.  Modulation of Protein-Interaction States through the Cell Cycle , 2018, Cell.

[7]  Peer Bork,et al.  Pervasive Protein Thermal Stability Variation during the Cell Cycle , 2018, Cell.

[8]  Anil Vasudevan,et al.  Emerging Approaches for the Identification of Protein Targets of Small Molecules - A Practitioners' Perspective. , 2018, Journal of medicinal chemistry.

[9]  P. Grandi,et al.  Multiplexed Proteome Dynamics Profiling Reveals Mechanisms Controlling Protein Homeostasis , 2018, Cell.

[10]  Chern Han Yong,et al.  Thermal proximity coaggregation for system-wide profiling of protein complex dynamics in cells , 2018, Science.

[11]  Jonathan L. Robinson,et al.  Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors , 2018, Molecular systems biology.

[12]  M. Gierliński,et al.  Thermal proteome profiling of breast cancer cells reveals proteasomal activation by CDK4/6 inhibitor palbociclib , 2017, bioRxiv.

[13]  M. Bantscheff,et al.  Thermal profiling reveals phenylalanine hydroxylase as an off-target of panobinostat. , 2016, Nature chemical biology.

[14]  G. Drewes,et al.  Thermal proteome profiling monitors ligand interactions with cellular membrane proteins , 2015, Nature Methods.

[15]  G. Superti-Furga,et al.  Proteome-wide drug and metabolite interaction mapping by thermal-stability profiling , 2015, Nature Methods.

[16]  G. Drewes,et al.  Thermal proteome profiling for unbiased identification of direct and indirect drug targets using multiplexed quantitative mass spectrometry , 2015, Nature Protocols.

[17]  John P. Overington,et al.  The promise and peril of chemical probes. , 2015, Nature chemical biology.

[18]  B. Shilton,et al.  Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT. , 2015, Biochemistry.

[19]  Teemu P. Miettinen,et al.  NQO2 Is a Reactive Oxygen Species Generating Off-Target for Acetaminophen , 2014, Molecular pharmaceutics.

[20]  G. Drewes,et al.  Tracking cancer drugs in living cells by thermal profiling of the proteome , 2014, Science.

[21]  P. Nordlund,et al.  Monitoring Drug Target Engagement in Cells and Tissues Using the Cellular Thermal Shift Assay , 2013, Science.

[22]  Jin-Ting Zhang,et al.  Analysis of Variance for Functional Data , 2013 .

[23]  Mark E Bunnage,et al.  Target validation using chemical probes. , 2013, Nature chemical biology.

[24]  Caroline F Finch,et al.  Applications of functional data analysis: A systematic review , 2013, BMC Medical Research Methodology.

[25]  B. Cravatt,et al.  Determining target engagement in living systems. , 2013, Nature chemical biology.

[26]  Hans-Georg Müller,et al.  Functional Data Analysis , 2016 .

[27]  Giovanni Montana,et al.  A statistical framework for biomarker discovery in metabolomic time course data , 2011, Bioinform..

[28]  William N. Venables,et al.  Modern Applied Statistics with S , 2010 .

[29]  A. Noordhof,et al.  In the absence of a gold standard , 2010 .

[30]  G. Superti-Furga,et al.  The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2) , 2009, BMC Structural Biology.

[31]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[32]  Bernhard Kuster,et al.  Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors , 2007, Nature Biotechnology.

[33]  John D. Storey,et al.  Significance analysis of time course microarray experiments. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Walter Krämer,et al.  Review of Modern applied statistics with S, 4th ed. by W.N. Venables and B.D. Ripley. Springer-Verlag 2002 , 2003 .

[35]  Joan G. Staniswalis,et al.  A similarity analysis of curves , 2002 .

[36]  A. Marazzi.  Bootstrap tests for robust means of asymmetric distributions with unequal shapes , 2002 .

[37]  Y. Benjamini,et al.  Controlling the false discovery rate in behavior genetics research , 2001, Behavioural Brain Research.

[38]  M. Wand.  Local Regression and Likelihood , 2001 .

[39]  Guohua Pan,et al.  Local Regression and Likelihood , 1999, Technometrics.

[40]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[41]  J. Schellman,et al.  The thermodynamics of solvent exchange , 1994, Biopolymers.

[42]  N. Ward,et al.  Kinetic analysis of protein kinase C inhibition by staurosporine: evidence that inhibition entails inhibitor binding at a conserved region of the catalytic domain but not competition with substrates. , 1992, Molecular pharmacology.

[43]  Morton B. Brown.  400: A Method for Combining Non-Independent, One-Sided Tests of Significance , 1975 .